Physical Activity in the Format of Self-defence Training for Depressive Symptoms

Sponsor
Chinese University of Hong Kong (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05313542
Collaborator
(none)
40
1
2
12
3.3

Study Details

Study Description

Brief Summary

Inadequate mental health care capacity is a long-standing issue in Hong Kong (Yang & Mak, 2020). For example, a recent study predicts an additional 12% service need for specialist psychiatric care (Ni et al., 2020). It would be helpful to develop interventions that would ease the high demand of the health care system. Physical activity has been shown to reduce depressive symptoms in a number of studies (Bellón et al., 2021; Josefsson et al., 2014; Kvam et al., 2018; Schuch et al., 2016). Its flexibility and low-cost nature make physical activity a good intervention option for depressed individuals to do it anytime and anywhere.

This study aims to investigate the effect of physical activity intervention in the format of self-defence training on depressive symptoms. Around 40 eligible participants with at least moderate level of depressive symptoms will be randomly assigned to the physical activity (PA) group and waitlist (WL) control group. The PA group will receive a 6-week home-based self-defence training programme consisting of 120 min video training (including daily practice time) per week. Self-report questionnaires will be collected at baseline, immediate post-intervention, and 4-week follow up assessments. The primary outcome measure will be the Patient Health Questionnaire-9 to evaluate depression severity. Secondary outcomes will include psychological health symptoms, sleep quality, lifestyle, and quality of life. This research will provide new perspectives on the application of physical activity in the form of self-defence training as an intervention for depressive individuals.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Physical Activity
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Physical Activity in the Format of Self-defence Training for Depressive Symptoms - A Pilot Randomised Controlled Trial
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Jun 30, 2023
Anticipated Study Completion Date :
Aug 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Physical Activity Group (PA group)

The PA group will receive a 6-week home-based self-defence training programme consisting of 120 min video training (including daily practice time) per week. Self-report questionnaires will be collected at baseline, immediate post-intervention, and 4-week follow up assessments.

Behavioral: Physical Activity
Physical Activity in the format of Self-defence Training

Other: Waitlist Group (WL group)

The waitlist group will receive access to the programme at the end of study.

Behavioral: Physical Activity
Physical Activity in the format of Self-defence Training

Outcome Measures

Primary Outcome Measures

  1. Change in the Patient Health Questionnaire (PHQ-9) [Baseline, immediately post-intervention, 4-week follow-up]

    The PHQ-9, a 20-item questionnaire used for screening, diagnosing, monitoring and measuring the severity of depression, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day).

Secondary Outcome Measures

  1. Change in the Short Form (Six-Dimension) Health Survey (SF-6D) [Baseline, immediately post-intervention, 4-week follow-up]

    SF-6D is a preference-based single index measure of health. A six-digit number represents each SF-6D health state, each digit denotes the level of one of six SF-6D dimensions: physical functioning, role limitation, social functioning, bodily pain, mental health, and vitality.

  2. Change in the International Physical Activities Questionnaire - Chinese version (IPAQ-C) [Baseline, immediately post-intervention, 4-week follow-up]

    Participants' sitting time, walking time and moderate and vigorous physical activity are assessed by 5 questions from the short form of the International Physical Activity Questionnaire - Chinese version. Participants' engagement in brief strength and stamina-enhancing activity were assessed by asking the number of days they engaged in physical activity while seated and standing in the last seven days.

  3. Change in the Insomnia Severity Index (ISI) [Baseline, immediately post-intervention, 4-week follow-up]

    The ISI is a 7-item scale designed to evaluate perceived insomnia severity. Ratings on the 5-point Likert scale are obtained on the perceived severity of sleep-onset, sleep-maintenance, early morning awakening problems, satisfaction with current sleep pattern, interference with daily functioning, noticeably of impairment attributed to the sleep problem, and level of distress caused by the sleep problem.

  4. Change in Hospital Anxiety and Depression Scale (HADS-14) [Baseline, immediately post-intervention, 4-week follow-up]

    HADS is a 14-item self-rated questionnaire which consists of two 7-item subscales that measure the presence of anxiety and depression symptoms respectively. Each item is rated on a 4-point-scale (0-3) by the participant. The greater the score, the more psychologically distressed the respondent is.

  5. Change in Multidimensional Fatigue Inventory (MFI-20) [Baseline, immediately post-intervention, 4-week follow-up]

    The MFI-20 assesses the severity of fatigue covering the following dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation and reduced activity.

  6. Change in Credibility-Expectancy Questionnaire (CEQ) [Baseline, immediately post-intervention, 4-week follow-up]

    The 6-item CEQ yielded ratings of treatment credibility, acceptability/satisfaction, and expectations for success.

  7. Change in Treatment Adherence Survey (TAS) [Baseline, immediately post-intervention]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 to 65 years old

  • Hong Kong Residents

  • Patient Health Questionnaire (PHQ-9) score ≥ 10; and

  • Willingness to provide informed consent and comply with the trial protocol.

Exclusion Criteria:
  • Patients with any cardiovascular diseases

  • Receiving psychological treatment or medication for psychiatric disorders

  • Participated in self defence training in the past 6 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Chinese University of Hong Kong Sha Tin Hong Kong

Sponsors and Collaborators

  • Chinese University of Hong Kong

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fiona YY Ho, Assistant Professor, Chinese University of Hong Kong
ClinicalTrials.gov Identifier:
NCT05313542
Other Study ID Numbers:
  • PSY021
First Posted:
Apr 6, 2022
Last Update Posted:
Jul 20, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Fiona YY Ho, Assistant Professor, Chinese University of Hong Kong
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 20, 2022